MYBL1 (MYB proto-oncogene like 1) functions as a transcription factor that plays critical roles in both normal development and cancer. In normal physiology, MYBL1 acts as a master regulator of male meiosis by promoting piRNA expression, which is essential for germline integrity through transposable element repression 1. The protein recognizes specific DNA sequences and activates transcription of genes involved in piRNA metabolism 1. In pathological contexts, MYBL1 alterations are frequently found in pediatric brain tumors, particularly low-grade gliomas, where rearrangements and fusions involving MYBL1 drive tumorigenesis 23. These alterations can include truncations without productive fusions that still result in gene overexpression 4. MYBL1 also promotes cancer progression in other malignancies, such as hepatocellular carcinoma, where it transcriptionally activates ANGPT2 to induce angiogenesis and confer drug resistance 5. Additionally, MYBL1 rearrangements serve as alternative drivers in breast adenoid cystic carcinomas lacking MYB-NFIB fusions 6. Clinically, MYBL1 alterations represent important diagnostic markers and potential therapeutic targets, particularly in pediatric gliomas where molecular classification guides treatment decisions 78.